Novo Nordisk (NVO) plans to launch its blockbuster weight-loss drug Wegovy in vial format. The move targets customers who have shifted to rival Eli Lilly & Co. (LLY).
This packaging change follows Eli Lilly’s lead in offering similar options for obesity treatments. Novo Nordisk currently distributes Wegovy exclusively through plastic injector pens.
The update aims to broaden accessibility and boost competitiveness in the growing market for weight management drugs.
Toll Brothers delivered strong first-quarter fiscal 2026 results, surpassing expectations with earnings per diluted share of $2.19 and total revenues…
Manhunt Ends with All Eight Fugitives CapturedA massive search operation concluded successfully after eight inmates, including three facing murder charges,…
Lucy Letby's parents have spoken out for the first time since their daughter's arrest, criticizing an upcoming Netflix documentary about…
Australia Breathes Easier as Heatwave SubsidesMillions across Australia can expect relief this week as a prolonged heatwave finally dissipates. The…
